PropertyValue
?:abstract
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global coronavirus disease 2019 (COVID-19) outbreak. Along with the respiratory tract, the gastrointestinal (GI) tract is one of the main extra-pulmonary targets of SARS-CoV-2 with respect to symptom occurrence and is a potential route for virus transmission, most likely due to the presence of angiotensin-converting enzyme 2. Therefore, understanding the mechanisms of GI injury is crucial for a harmonized therapeutic strategy against COVID-19. This review summarizes the current evidence for the clinical features of and possible pathogenic mechanisms leading to GI injury in COVID-19.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.3390/jcm9113630
?:journal
  • J_Clin_Med
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/b9fe5c94d047a29a9b4ce1c21eb31142eff0dcf0.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7696882.xml.json
?:pmcid
?:pmid
?:pmid
  • 33187280.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19
?:type
?:year
  • 2020-11-11

Metadata

Anon_0  
expand all